Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”

What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

with the saying: He who laughs last laughs best, writes Samuel Lagercrantz in an editorial.

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Rekordstor donation till cancerforskning i Lund – ”Once in a lifetime-möjlighet”

Lunds universitet får den största donationen i lärosätets moderna historia, enligt ett pressmeddelande.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Kolla in vår vakuumskola!

Vakuumteknologi spelar en central roll inom många industriella processer och används för att hantera och förflytta objekt på ett effektivt sätt. Genom att använ...

Karolinska trea på europeisk innovationslista – men franskt sjukhus dominerar

Karolinska universitetssjukhuset placerar sig på tredje plats bland Europas forskningssjukhus när det gäller patentansökningar på medicinska innovationer.

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

To build trust, one must be able to say “I don’t know” – whether human or AI

Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

Will the FDA’s new transparency policy extend to medical devices? (Part 1)

In a significant policy shift, the FDA has begun publishing Complete Response Letters (CRLs) for drug and biologic applications that were initially rejected but...

Har du kommit ihåg vinterjackan?

Hösten är snart över och vintern står för dörren.. Men det är inte bara människor som behöver extra kläder när kylan kommer. Även dina ångkomponenter kan behöva...

Dansk aktör köper krisande amerikanskt cancerbolag

Danska Pharmacosmos tar över det amerikanska läkemedelsbolaget G1 Therapeutics i en affär som uppgår till 405 miljoner dollar.

How Volume EM Advances Life Science Research

Free webinar series.

Lilly köper genterapibolag till reapris

Läkemedelsjätten Eli Lilly kliver in och köper upp Adverum Biotechnologies och dess genterapi i sen klinisk fas – en affär som sker just när det Kalifornienbase...

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

Nanexa finalist i Fierce Innovation Awards

Uppsalabolaget Nanexa har utsetts till finalist i den internationella tävlingen Fierce Innovation Awards Life Sciences. Bolaget uppmärksammas i kategorin Drug D...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Column: ”We need to exploit the benefits of the regulations“

You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good condit...

Babypuderskandalen når Europa – första stämningen mot J&J i Storbritannien

De enorma skadeståndsprocesserna mot Johnson & Johnson, vars talkpuder påstås ha orsakat cancer, har nu även nått Storbritannien.

Cytel Sweden

Noxious parasite forms hybrids and deceives the immune system

The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to decei...